A decision tree for the genetic diagnosis of deficiency of adenosine deaminase 2 (DADA2): a French reference centres experience
- 23 April 2018
- journal article
- research article
- Published by Springer Nature in European Journal of Human Genetics
- Vol. 26 (7) , 960-971
Abstract
Deficiency of adenosine deaminase 2 (DADA2) is a recently described autoinflammatory disorder. Genetic analysis is required to confirm the diagnosis. We aimed to describe the identifying symptoms and genotypes of patients referred to our reference centres and to improve the indications for genetic testing. DNA from 66 patients with clinically suspected DADA2 were sequenced by Sanger or next-generation sequencing. Detailed epidemiological, clinical and biological features were collected by use of a questionnaire and were compared between patients with and without genetic confirmation of DADA2. We identified 13 patients (19.6%) carrying recessively inherited mutations in ADA2 that were predicted to be deleterious. Eight patients were compound heterozygous for mutations. Seven mutations were novel (4 missense variants, 2 predicted to affect mRNA splicing and 1 frameshift). The mean age of the 13 patients with genetic confirmation was 12.7 years at disease onset and 20.8 years at diagnosis. Phenotypic manifestations included fever (85%), vasculitis (85%) and neurological disorders (54%). Features best associated with a confirmatory genotype included fever with neurologic or cutaneous attacks (odds ratio [OR] 10.71, p = 0.003 and OR 10.9, p < 0.001), fever alone (OR 8.1, p = 0.01), and elevated C-reactive protein (CRP) level with neurologic involvement (OR 6.63, p = 0.017). Our proposed decision tree may help improve obtaining genetic confirmation of DADA2 in the context of autoinflammatory symptoms. Prerequisites for quick and low-cost Sanger analysis include one typical cutaneous or neurological sign, one marker of inflammation (fever or elevated CRP level), and recurrent or chronic attacks in adults.Keywords
This publication has 23 references indexed in Scilit:
- Unexplained early-onset lacunar stroke and inflammatory skin lesions: Consider ADA2 deficiencyNeurology, 2015
- Evidence-based provisional clinical classification criteria for autoinflammatory periodic feversAnnals of the Rheumatic Diseases, 2015
- Hematopoietic stem cell transplantation rescues the immunologic phenotype and prevents vasculopathy in patients with adenosine deaminase 2 deficiencyJournal of Allergy and Clinical Immunology, 2015
- Mutations in CECR1 associated with a neutrophil signature in peripheral bloodPediatric Rheumatology, 2014
- Mutant Adenosine Deaminase 2 in a Polyarteritis Nodosa VasculopathyNew England Journal of Medicine, 2014
- Early-Onset Stroke and Vasculopathy Associated with Mutations in ADA2New England Journal of Medicine, 2014
- Human adenosine deaminase 2 induces differentiation of monocytes into macrophages and stimulates proliferation of T helper cells and macrophagesJournal of Leukocyte Biology, 2010
- Structural Basis for the Growth Factor Activity of Human Adenosine Deaminase ADA2Journal of Biological Chemistry, 2010
- Human ADA2 belongs to a new family of growth factors with adenosine deaminase activityBiochemical Journal, 2005
- Infevers: An evolving mutation database for auto-inflammatory syndromesHuman Mutation, 2004